Document Detail

Tumour necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family.
MedLine Citation:
PMID:  14610673     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Although tumour necrosis factor receptor-associated periodic syndrome has been reported mainly in families of northern European ancestry, our case suggests the need to include it in the differential diagnosis of patients with recurrent fever even in ethnic groups in which no case has been documented.
Koichi Kusuhara; Akihiko Nomura; Futoshi Nakao; Toshiro Hara
Related Documents :
12395673 - Clinical presentation of vitiligo.
3585943 - Angelman (happy puppet) syndrome in a girl and her brother.
4092703 - Pasteurella ureae meningitis as complication of skull fractures.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2003-11-11
Journal Detail:
Title:  European journal of pediatrics     Volume:  163     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2003-12-16     Completed Date:  2004-06-08     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  30-2     Citation Subset:  IM    
Department of Paediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higahi-ku, 812-8582 Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Familial Mediterranean Fever / ethnology*,  genetics*
Receptors, Tumor Necrosis Factor / genetics*
Receptors, Tumor Necrosis Factor, Type II
Reg. No./Substance:
0/Receptors, Tumor Necrosis Factor; 0/Receptors, Tumor Necrosis Factor, Type II; 0/TNFRSF1B protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Group A streptococcal meningitis as a complication of an infected capillary haemangioma.
Next Document:  Lysosomal storage disorders: emerging therapeutic options require early diagnosis.